LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $913,370 | -92.5% | 16,284 | -91.9% | 0.00% | -95.8% |
| Q4 2023 | $12,162,523 | +7782.9% | 202,136 | +8700.0% | 0.02% | – |
| Q3 2023 | $154,289 | -86.0% | 2,297 | -89.6% | 0.00% | -100.0% |
| Q4 2022 | $1,105,928 | -74.7% | 22,154 | -79.4% | 0.01% | -76.9% |
| Q3 2022 | $4,377,000 | +301.2% | 107,291 | +257.3% | 0.03% | +188.9% |
| Q1 2022 | $1,091,000 | +429.6% | 30,032 | +521.4% | 0.01% | +200.0% |
| Q2 2020 | $206,000 | – | 4,833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 560,506 | $26,125,000 | 18.14% |
| JOHNSON & JOHNSON | 1,629,173 | $75,936,000 | 8.64% |
| HHLR ADVISORS, LTD. | 11,804,925 | $550,228,000 | 8.50% |
| Paradigm Biocapital Advisors LP | 385,967 | $17,990,000 | 5.14% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,004,742 | $46,831,000 | 4.89% |
| Yong Rong (HK) Asset Management Ltd | 130,000 | $6,060,000 | 4.79% |
| Old Well Partners, LLC | 79,700 | $3,715,000 | 2.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $9,322,000 | 1.88% |
| Tri Locum Partners LP | 89,840 | $4,187,000 | 1.65% |
| INDUS CAPITAL PARTNERS, LLC | 123,054 | $5,736,000 | 1.36% |